Sun Pharma site hit with second Form 483 in 3 years
An Indian pharma with a manufacturing site in Gujarat has been slapped with a Form 483 from the FDA after inspections that ended yesterday resulted …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
